Literature DB >> 26148276

Long-Term Prognosis After Coronary Artery Calcification Testing in Asymptomatic Patients: A Cohort Study.

Leslee J Shaw, Ashley E Giambrone, Michael J Blaha, Joseph T Knapper, Daniel S Berman, Naveen Bellam, Arshed Quyyumi, Matthew J Budoff, Tracy Q Callister, James K Min.   

Abstract

BACKGROUND: The extent of coronary artery calcification (CAC) and near-term adverse clinical outcomes are strongly related through 5 years of follow-up.
OBJECTIVE: To describe the ability of CAC scores to predict long-term mortality in persons without symptoms of coronary artery disease.
DESIGN: Observational cohort.
SETTING: Single-center, outpatient cardiology laboratory. PATIENTS: 9715 asymptomatic patients. MEASUREMENTS: Coronary artery calcification scoring and binary risk factor data were collected. The primary end point was time to all-cause mortality (median follow-up, 14.6 years). Univariable and multivariable Cox proportional hazards models were used to compare survival distributions. The net reclassification improvement statistic was calculated.
RESULTS: In Cox models adjusted for risk factors for coronary artery disease, the CAC score was highly predictive of all-cause mortality (P < 0.001). Overall 15-year mortality rates ranged from 3% to 28% for CAC scores from 0 to 1000 or greater (P < 0.001). The relative hazard for all-cause mortality ranged from 1.68 for a CAC score of 1 to 10 (P < 0.001) to 6.26 for a score of 1000 or greater (P < 0.001). The categorical net reclassification improvement using cut points of less than 7.5% to 22.5% or greater was 0.21 (95% CI, 0.16 to 0.32). LIMITATIONS: Data collection was limited to a single center with generalizability limitations. Only binary risk factor data were available, and CAC was only measured once.
CONCLUSION: The extent of CAC accurately predicts 15-year mortality in a large cohort of asymptomatic patients. Long-term estimates of mortality provide a unique opportunity to examine the value of novel biomarkers, such as CAC, in estimating important patient outcomes. PRIMARY FUNDING SOURCE: None.

Entities:  

Mesh:

Year:  2015        PMID: 26148276     DOI: 10.7326/M14-0612

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  41 in total

1.  The benefits of advanced risk reclassification.

Authors:  Parham Eshtehardi; Ijeoma Isiadinso; Leslee J Shaw
Journal:  J Nucl Cardiol       Date:  2015-09-22       Impact factor: 5.952

Review 2.  Relationship between Calcium Score and Myocardial Scintigraphy in the Diagnosis of Coronary Disease.

Authors:  Fabio Paiva Rossini Siqueira; Claudio Tinoco Mesquita; Alair Augusto Sarmet M Damas Dos Santos; Marcelo Souto Nacif
Journal:  Arq Bras Cardiol       Date:  2016-07-18       Impact factor: 2.000

3.  Coronary artery calcium scoring in low risk patients with family history of coronary heart disease: Validation of the SCCT guideline approach in the coronary artery calcium consortium.

Authors:  Ramzi Dudum; Omar Dzaye; Mohammadhassan Mirbolouk; Zeina A Dardari; Olusola A Orimoloye; Matthew J Budoff; Daniel S Berman; Alan Rozanski; Michael D Miedema; Khurram Nasir; John A Rumberger; Leslee Shaw; Seamus P Whelton; Garth Graham; Michael J Blaha
Journal:  J Cardiovasc Comput Tomogr       Date:  2019-03-27

4.  Sex differences in calcified plaque and long-term cardiovascular mortality: observations from the CAC Consortium.

Authors:  Leslee J Shaw; James K Min; Khurram Nasir; Joe X Xie; Daniel S Berman; Michael D Miedema; Seamus P Whelton; Zeina A Dardari; Alan Rozanski; John Rumberger; C Noel Bairey Merz; Mouaz H Al-Mallah; Matthew J Budoff; Michael J Blaha
Journal:  Eur Heart J       Date:  2018-11-01       Impact factor: 29.983

5.  Rationale and design of a randomized trial of apixaban vs warfarin to evaluate atherosclerotic calcification and vulnerable plaque progression.

Authors:  Kazuhiro Osawa; Rine Nakanishi; Theingi Tiffany Win; Dong Li; Sina Rahmani; Negin Nezarat; Nasim Sheidaee; Matthew J Budoff
Journal:  Clin Cardiol       Date:  2017-07-13       Impact factor: 2.882

6.  Coronary Calcium Scoring as the Gate Keeper for Stress Myocardial Perfusion Imaging: Antagonist.

Authors:  Shane M Ruckel; Martha Gulati
Journal:  J Nucl Cardiol       Date:  2017-01-31       Impact factor: 5.952

7.  A need to reduce premature CV mortality in the developing world: How could appropriate use of non-invasive imaging help?

Authors:  João V Vitola
Journal:  J Nucl Cardiol       Date:  2018-11-20       Impact factor: 5.952

8.  Association between Intracranial Atherosclerotic Calcium Burden and Angiographic Luminal Stenosis Measurements.

Authors:  H Baradaran; P Patel; G Gialdini; A Giambrone; M P Lerario; B B Navi; J K Min; C Iadecola; H Kamel; A Gupta
Journal:  AJNR Am J Neuroradiol       Date:  2017-07-20       Impact factor: 3.825

Review 9.  Cardiovascular disease in patients with severe mental illness.

Authors:  René Ernst Nielsen; Jytte Banner; Svend Eggert Jensen
Journal:  Nat Rev Cardiol       Date:  2020-10-30       Impact factor: 32.419

10.  The Association of Coronary Artery Calcium With Noncardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Catherine E Handy; Chintan S Desai; Zeina A Dardari; Mouaz H Al-Mallah; Michael D Miedema; Pamela Ouyang; Matthew J Budoff; Roger S Blumenthal; Khurram Nasir; Michael J Blaha
Journal:  JACC Cardiovasc Imaging       Date:  2016-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.